|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
FY2021
12 months to Jan 2, 2022
|
|
|---|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Operating activities: | |||||
| Net income | |||||
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | |||||
| Income from continuing operations | |||||
| Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations: | |||||
| Restructuring and other costs, net | |||||
| Restructuring Charges and Changes in Estimates | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Pension and other post-retirement expense | |||||
| Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) | |||||
| Deferred taxes | |||||
| Contingencies and Non-Cash Tax Matters | |||||
| Amortization of deferred debt issuance costs, interest rate hedge and accretion of discounts | |||||
| Gain on disposition of businesses and assets, net | |||||
| Amortization of acquired inventory revaluation | |||||
| Asset Impairment Charges | |||||
| Change in fair value of investments | |||||
| Gain (Loss) on Extinguishment of Debt | |||||
| Unrealized Gain (Loss), Foreign Currency Transaction, before Tax | |||||
| Changes in assets and liabilities which (used) provided cash, excluding effects from companies purchased and divested: | |||||
| Accounts receivable, net | |||||
| Inventories, net | |||||
| Accounts payable | |||||
| Accrued expenses and other | |||||
| Net cash provided by operating activities of continuing operations | |||||
| Net cash used in operating activities of discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Purchases of investments and notes receivables | |||||
| Payments to Acquire Marketable Securities | |||||
| Proceeds from Sale and Maturity of Marketable Securities | |||||
| Proceeds from investments and notes receivables | |||||
| Proceeds from Divestiture of Businesses | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Net cash (used in) provided by investing activities of continuing operations | |||||
| Net cash provided by investing activities of discontinued operations | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities: | |||||
| Payments on revolving credit facility | |||||
| Proceeds from Long-term Lines of Credit | |||||
| Payments of Senior Debt | |||||
| Proceeds from sale of senior debt | |||||
| Payments of debt financing and equity issuance costs | |||||
| Proceeds from (Repayments of) Other Debt | |||||
| Settlement of cash flow hedges | |||||
| Settlement of swaps | |||||
| Payments for acquisition-related contingent consideration | |||||
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | |||||
| Purchases of common stock | |||||
| Dividends paid | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash and cash equivalents at beginning of year | |||||
| Restricted Cash, Current | |||||
| Restricted Cash, Noncurrent | |||||
| Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest Paid, Excluding Capitalized Interest, Operating Activity | |||||
| Income taxes | |||||
| Cash Flow, Noncash Investing and Financing Activities Disclosure | |||||
| Consideration receivable from sale of Business | |||||
| Equity issued for business combination, net of issuance costs | |||||
Loading...